Lamivudine
CHEBI:CHEBI_63577
Definition
A monothioacetal that consists of cytosine having a (2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl moiety attached at position 1. An inhibitor of HIV-1 reverse transcriptase, it is used as an antiviral in the treatment of AIDS and hepatitis B.
Chemical Information
- Molecular Formula
- C8H11N3O3S
- Molecular Mass
- 229.25600
- Charge
- 0
- SMILES
- Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1
- InChI
- InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1
- InChIKey
- JTEGQNOMFQHVDC-NKWVEPMBSA-N
Alternative Names
- (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
- (-)-2'-Deoxy-3'-thiacytidine
- 2',3'-Dideoxy-3'-thiacytidine
- 3'-Thia-2',3'-dideoxycytidine
- 3TC
- 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
- beta-L-2',3'-Dideoxy-3'-thiacytidine
- beta-L-3'-Thia-2',3'-dideoxycytidine
- Epivir
- lamivudine
- Lamivudine
Treatment Applications
Drug Classification
-
nucleoside analogueView Class →
CHEBI:60783
-
primary alcoholView Class →
CHEBI:15734
-
oxacycleView Class →
CHEBI:38104
-
monothioacetalView Class →
CHEBI:59793
-
t262113
-
t262200
-
t262275
-
t262309
-
t262435
-
t262595
-
t262921
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- oboInOwl#hasDbXref
- Wikipedia:Lamivudine
- DRON_00010000
- 68244
- core#notation
- CHEBI:63577
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- dosage_form
- SOLUTION
- labeler_name
- XLCare Pharmaceuticals, Inc
- application_number
- ANDA077558
- product_ndc
- 60505-3252
- package_description
- 35000 TABLET, FILM COATED in 1 DRUM (53873-074-00)
- package_ndc
- 31722-752-32
- listing_expiration_date
- 20241231
- route
- ORAL
- marketing_start_date
- 19951117
- spl_id
- c4e0edda-dad5-4bed-b108-b6aae30e3be3
- package_marketing_start_date
- 17-NOV-95
- rxcui
- 2003255
- active_ingredient_strength
- 50 kg/50kg
- manufacturer_name
- XLCare Pharmaceuticals, Inc
- active_ingredient_name
- ZIDOVUDINE
- unii
- 4B9XT59T7S
- nui
- N0000175656
- spl_set_id
- d40292ff-046c-4a04-b801-10768667951a
- upc
- 0349702203181
- has_treatment
- http://purl.obolibrary.org/obo/DOID_5497
- owl#someValuesFrom
- t1039554
- oboInOwl#hasOBONamespace
- chebi_ontology
- oboInOwl#hasDbXref
- Wikipedia:Lamivudine
- DRON_00010000
- 68244
- oboInOwl#id
- CHEBI:63577
- oboInOwl#hasAlternativeId
- CHEBI:6366
- generic_name
- lamivudine oral
- brand_name
- EPIVIR
- brand_name_base
- EPIVIR
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_50266
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- chebi#has_functional_parent
- http://purl.obolibrary.org/obo/CHEBI_16040
- core#notation
- CHEBI:63577
- brand_name_suffix
- HBV
- pharm_class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- pharm_class_epc
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- pharm_class_moa
- Nucleoside Reverse Transcriptase Inhibitors [MoA]
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_112557
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect30411
- owl#annotatedSource
- t262969